Substituted benzazoles and methods of their use as inhibitors of Raf kinase
US7423150B2 · kind B2 · utility
14Cited by
4References
48Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 15, 2004 |
| Grant date | Sep 9, 2008 |
| Priority date | — |
| Expiry date | Dec 1, 2025 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
New substituted benzazole compounds, compositions and methods of inhibition of Raf kinase activity in a human or animal subject are provided. The new compounds compositions may be used either alone or in combination with at least one additional agent for the treatment of a Raf kinase mediated disorder, such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.